{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:57:28Z","timestamp":1793195848361,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.psychres.2010.11.021","type":"journal-article","created":{"date-parts":[[2011,1,8]],"date-time":"2011-01-08T09:12:30Z","timestamp":1294477950000},"page":"21-25","source":"Crossref","is-referenced-by-count":30,"title":["Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics"],"prefix":"10.1016","volume":"189","author":[{"given":"Bjanka","family":"Vuksan-\u0106usa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miro","family":"Jakovljevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"\u0160agud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Mihaljevi\u0107 Pele\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Mar\u010dinko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radmila","family":"Topi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanea","family":"Mihaljevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadranka","family":"Serti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13\u201314","key":"10.1016\/j.psychres.2010.11.021_bb0005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.clinbiochem.2007.06.001","article-title":"Associations of blood homocysteine concentrations in Arab schizophrenic patients","volume":"40","author":"Akanji","year":"2007","journal-title":"Clinical Biochemistry"},{"issue":"4","key":"10.1016\/j.psychres.2010.11.021_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jpsychires.2004.01.003","article-title":"Homocysteine levels in newly admitted schizophrenic patients","volume":"38","author":"Applebaum","year":"2004","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1016\/j.psychres.2010.11.021_bb0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.plefa.2003.12.009","article-title":"Fatty acids and homocysteine levels in patients with reccurent depression: an explorative pilot study","volume":"70","author":"Assies","year":"2004","journal-title":"Prostaglandines, Leukotrienes & Essentials Fatty Acids"},{"issue":"6","key":"10.1016\/j.psychres.2010.11.021_bb0020","first-page":"999","article-title":"Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease","volume":"3","author":"Bellia","year":"2007","journal-title":"Journal of Therapeutics and Clinical Risk Management"},{"issue":"6","key":"10.1016\/j.psychres.2010.11.021_bb0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4088\/JCP.v68n0614","article-title":"The level of cardiovascular risk-factors in bipolar disorder equals that of schizophrenia: a comparative study","volume":"68","author":"Birkenaes","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2010.11.021_bb0030","article-title":"Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study","author":"Bobes","year":"2010","journal-title":"European Psychiatry, 29 October, electronic publication"},{"issue":"8","key":"10.1016\/j.psychres.2010.11.021_bb0035","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1373\/clinchem.2005.054122","article-title":"Homocysteine Stability in Heparinized Plasma Stored in a Gel Separator Tube","volume":"51","author":"Calam","year":"2005","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.psychres.2010.11.021_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.05.030","article-title":"Modal subcomponents of metabolic syndrome in patients with bipolar disorder","volume":"106","author":"Cardenas","year":"2008","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.psychres.2010.11.021_bb0045","first-page":"62","article-title":"Update on cobalamin, folate and homocysteine","author":"Carmel","year":"2003"},{"issue":"7","key":"10.1016\/j.psychres.2010.11.021_bb0050","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1399-5618.2008.00625.x","article-title":"Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics","volume":"10","author":"Corell","year":"2008","journal-title":"Bipolar Disorders"},{"issue":"2B","key":"10.1016\/j.psychres.2010.11.021_bb0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1079\/PHN2001159","article-title":"MTHFR polymorphism, homocysteine and cardiovascular disease","volume":"4","author":"Cortese","year":"2001","journal-title":"Public Health Nutrition"},{"issue":"2","key":"10.1016\/j.psychres.2010.11.021_bb0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-2005-872398","article-title":"Effect of drugs on homocysteine concentrations","volume":"5","author":"Dierkes","year":"2005","journal-title":"Seminars in Vascular Medicine"},{"issue":"6","key":"10.1016\/j.psychres.2010.11.021_bb0065","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4088\/JCP.v69n0603","article-title":"The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study","volume":"69","author":"Dittman","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2010.11.021_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1399-5618.2007.00412.x","article-title":"Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results","volume":"9","author":"Dittmann","year":"2007","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.psychres.2010.11.021_bb0075","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"The Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Executive Summary","year":"2001","journal-title":"Journal of American Medical Association"},{"key":"10.1016\/j.psychres.2010.11.021_bb0080","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-5618.2005.00234.x","article-title":"Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians","volume":"7","author":"Fagiollini","year":"2005","journal-title":"Bipolar Disorders"},{"issue":"3","key":"10.1016\/j.psychres.2010.11.021_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.psychres.2008.05.009","article-title":"Association of plasma homocysteine and methylentetrahydrofolate reductase C677T gene variant with schizophrenia: A Chinese Han population \u2013based case-control study","volume":"168","author":"Feng","year":"2009","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1016\/j.psychres.2010.11.021_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/met.2006.4.185","article-title":"Is hyperhomocysteinemia an additional risk factor of the metabolic syndrome?","volume":"4","author":"Garcin","year":"2006","journal-title":"Metabolic Syndrome Related Disorders"},{"issue":"7","key":"10.1016\/j.psychres.2010.11.021_bb0095","doi-asserted-by":"crossref","first-page":"631-637","DOI":"10.1136\/jech.2006.050385","article-title":"Is low folate a risk factor for depression? A meta analysis and exploration of heterogeneity","volume":"61","author":"Gilbody","year":"2007","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"4","key":"10.1016\/j.psychres.2010.11.021_bb0100","first-page":"204","article-title":"Metabolic syndrome: What are the risks for humans?","volume":"5","author":"Gupta","year":"2010","journal-title":"BioScience Trends"},{"key":"10.1016\/j.psychres.2010.11.021_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"Rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2010.11.021_bb0110","first-page":"515","article-title":"Review of role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders-current evidence and preliminary recommendations","volume":"75","author":"Hermann","year":"2007","journal-title":"Fortschritte der Neurologie- Psychiatrie"},{"issue":"7","key":"10.1016\/j.psychres.2010.11.021_bb0115","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/jn\/134.7.1832","article-title":"Hyperhomocysteinemia in healthy young men and elderly men with normal serum folate concentration is not associated with poor vascular reactivity or oxidative stress","volume":"134","author":"Hirsch","year":"2004","journal-title":"Journal of Nutrition"},{"key":"10.1016\/j.psychres.2010.11.021_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2010.11.021_bb0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1176\/appi.psy.48.5.412","article-title":"Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder","volume":"48","author":"Kilbourne","year":"2007","journal-title":"Psychosomatics"},{"issue":"10","key":"10.1016\/j.psychres.2010.11.021_bb0130","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1176\/appi.ajp.159.10.1790","article-title":"Elevated homocysteine levels in young male patients with schizophrenia","volume":"159","author":"Levine","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2010.11.021_bb0135","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.pnpbp.2005.06.029","article-title":"High homocysteine levels in young male schizophrenia and bipolar patients and in an animal model","volume":"29","author":"Levine","year":"2005","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2010.11.021_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/157016106777698360","article-title":"Drug therapy in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions","volume":"4","author":"Lonn","year":"2006","journal-title":"Current Vascular Pharmacology"},{"issue":"7","key":"10.1016\/j.psychres.2010.11.021_bb0145","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0002-9343(02)01021-5","article-title":"Homocysteine and cardiovascular disease: current evidence and future prospects","volume":"112","author":"Mangoni","year":"2002","journal-title":"American Journal of Medicine"},{"issue":"9","key":"10.1016\/j.psychres.2010.11.021_bb0150","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.162.9.1738","article-title":"Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type","volume":"162","author":"Neeman","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2010.11.021_bb0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.0000108926.04022.0C","article-title":"Association of the metabolic syndrome with history of myocardial infarction and stroke in The Third National Health and Nutritional Examination Survey","volume":"109","author":"Ninomiya","year":"2004","journal-title":"Circulation"},{"issue":"13\u201314","key":"10.1016\/j.psychres.2010.11.021_bb0160","first-page":"1026","article-title":"Homocysteine and lipids; S-adenosylmethionine as a key intermediate","volume":"40","author":"Obeid","year":"2007","journal-title":"Clinical Biochemistry"},{"issue":"1","key":"10.1016\/j.psychres.2010.11.021_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1399-5618.2003.00082.x","article-title":"Elevated homocysteine levels in euthymic bipolar disorder patients showing functional deterioration","volume":"6","author":"Osher","year":"2004","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.psychres.2010.11.021_bb0170","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.pnpbp.2008.04.016","article-title":"Effect of the methylentetra hydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives","volume":"32","author":"Ozbek","year":"2008","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2010.11.021_bb0175","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00392-006-0351-5","article-title":"Gender differences in the metabolic syndrome and their role for cardiovascular disease","volume":"95","author":"Regitz-Zagrosek","year":"2006","journal-title":"Clinical Research in Cardiology"},{"key":"10.1016\/j.psychres.2010.11.021_bb0180","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.pnpbp.2005.06.027","article-title":"Homocysteinemia as well as methylentetrahydrofolate reductase polymorphism are associated with affective psychoses","author":"Reif","year":"2005","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2010.11.021_bb0185","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/0269881107077609","article-title":"Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment","volume":"21","author":"Sarandol","year":"2007","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.psychres.2010.11.021_bb0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0003-2697(87)90026-1","article-title":"Quantitation of total homocysteine, total cysteine and methionine in normal serum and urine using capillary gas chromatography- mass spectrometry","volume":"162","author":"Stabler","year":"1987","journal-title":"Analytical Biochemistry"},{"issue":"9","key":"10.1016\/j.psychres.2010.11.021_bb0195","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1586\/ern.09.75","article-title":"Homocysteine, folate and vitamin B (12) in neuropsychiatric diseases: review and treatment recommendations","volume":"9","author":"Stanger","year":"2009","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.psychres.2010.11.021_bb0200","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.metabol.2010.05.016","article-title":"Hyperhomocysteinemia in patients with acute intermittent porphyria","volume":"59","author":"To-Figueras","year":"2010","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.psychres.2010.11.021_bb0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pnpbp.2008.10.017","article-title":"Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts","volume":"33","author":"Vuksan-\u0106usa","year":"2009","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.11.021_bb0210","series-title":"World Health Organization International Statistical Classification of Diseases and Related Health Problems, Tenth Revision","author":"World Health Organization","year":"1996"},{"key":"10.1016\/j.psychres.2010.11.021_bb0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"British Journal of Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178110007134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178110007134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T18:11:58Z","timestamp":1559931118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178110007134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0165178110007134"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2010.11.021","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}